OMX Helsinki — S&P 500 — DAX — NASDAQ 100 — STOXX 600 — EUR/USD — EUR/SEK — BTC/USD — ETH/USD — Euribor 3 kk — Euribor 12 kk —
Business Finland

Business Finland

Johtaminen, kasvu ja bisneksen kehittäminen 1,970 tilaajat

Finnish Biobanks as Biodata Resources: From FinnGen to Fingenious

27.10.2020 31 katselut
Julkaistu: 27.10.2020 Kategoria: Johtaminen, kasvu ja bisneksen kehittäminen Katselut: 31

Jakson tiedot

Jakson kuvaus

Finnish biobanks have joined together in a large nationwide project called FinnGen, which will generate a vast amount of genome data from up to 500,000 biobank sample donors. The collaborative project aims to improve human health through genetic research, and ultimately identify new therapeutic targets and diagnostics for treating numerous diseases. All sample-related genome data will return to the originating biobank where it can be further utilized in subsequent biobank studies. Fingenious® is the one-stop digital portal that provides researchers with a fast access to Finnish biobanks’ high-quality specimens and biodata, including genome data returned from FinnGen. In addition, information on possibility to find specific patients for further biomedical studies can be linked to samples. In this session we will discuss the value of Finnish biobank data in development of new treatments. Speakers: Professor Aarno Palotie, Scientific Director of the FinnGen Project, Institute for Molecular Medicine Finland (FIMM), University of Helsinki Marco Hautalahti, CEO, Finnish Biobank Cooperative (FINBB)

Avaa tekoälyavustajan chat. Chat ladataan vasta, kun avaat sen.